Cargando…
恶性血液病单倍型造血干细胞移植预处理中兔抗人胸腺细胞球蛋白剂量优化探讨
OBJECTIVE: To compare the clinical efficacy of different doses of rabbit antithymocyte globulin (rATG) in haplo-HSCT in the treatment of hematologic malignancies. METHODS: Malignant hematological patients treated at our hospital from March 2013 to December 2018 were retrospectively analyzed. These p...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449780/ https://www.ncbi.nlm.nih.gov/pubmed/32810962 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.07.005 |
Ejemplares similares
-
兔抗人胸腺细胞免疫球蛋白用于血液病患者第二次异基因造血干细胞移植的安全性
Publicado: (2022) -
两种兔抗人胸腺细胞免疫球蛋白给药方案同胞全相合造血干细胞移植治疗恶性血液病的临床研究
Publicado: (2023) -
猪抗人淋巴细胞球蛋白与兔抗人胸腺细胞球蛋白治疗重型再生障碍性贫血儿童的疗效比较
Publicado: (2019) -
低剂量抗胸腺细胞球蛋白在供、受者年龄均≥40岁恶性血液病同胞相合外周血干细胞移植中的应用
Publicado: (2018) -
减低剂量预处理单倍型外周血造血干细胞移植治疗50岁以上恶性血液肿瘤患者的临床研究
Publicado: (2019)